Regeneron Pharmaceuticals Worst Performer in the S&P 500 and Nasdaq 100 So Far Today — Data Talk
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $1046.33, down $45.65 or 4.18%
--Would be lowest close since July 5, 2024, when it closed at $1034.23
--Currently down seven of the past eight days
--Currently down three consecutive days; down 9.03% over this period
--Worst three day stretch since the three days ending June 29, 2023, when it fell 9.68%
--Down 11.68% month-to-date; on pace for worst month since May 2019, when it fell 12.07%
--Up 19.13% year-to-date
--Down 12.93% from its all-time closing high of $1201.76 on Aug. 27, 2024
--Up 25.7% from 52 weeks ago (Sept. 26, 2023), when it closed at $832.41
--Down 12.93% from its 52-week closing high of $1201.76 on Aug. 27, 2024
--Up 34.98% from its 52-week closing low of $775.18 on Oct. 27, 2023
--Traded as low as $1043.84; lowest intraday level since Aug. 1, 2024, when it hit $1041.85
--Down 4.41% at today's intraday low
--Worst performer in the S&P 500 today
--Worst performer in the Nasdaq 100 today
All data as of 10:23:45 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 24, 2024 10:42 ET (14:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk